A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report

BACKGROUND: The use of chemotherapy to manage newly diagnosed low grade glioma (LGG) was first introduced in the 1980s. One randomised trial has studied two- versus four-drug regimens with a duration of 12 months of treatment after resection. METHODS: Within the European comprehensive treatment stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Gnekow, Astrid K., Walker, David A., Kandels, Daniela, Picton, Susan, Giorgio Perilongo, Grill, Jacques, Stokland, Tore, Sandstrom, Per Eric, Warmuth-Metz, Monika, Pietsch, Torsten, Giangaspero, Felice, Schmidt, René, Faldum, Andreas, Kilmartin, Denise, De Paoli, Angela, De Salvo, Gian Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2017
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517338/
https://www.ncbi.nlm.nih.gov/pubmed/28649001
http://dx.doi.org/10.1016/j.ejca.2017.04.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517338/
https://www.ncbi.nlm.nih.gov/pubmed/28649001
http://dx.doi.org/10.1016/j.ejca.2017.04.019

Ejemplares similares